Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Bilastine
Drug ID BADD_D02615
Description Bilastine is a novel new-generation antihistamine that is highly selective for the H1 histamine receptor, has a rapid onset and prolonged duration of action.
Indications and Usage For symptomatic relief of nasal and non-nasal symptoms of seasonal rhinitis in patients 12 years of age and older and for symptomatic relief in chronic spontaneous urticaria in patients 18 years of age and older [FDA Label].
Marketing Status approved; investigational
ATC Code R06AX29; S01GX13
DrugBank ID DB11591
KEGG ID D09570
MeSH ID C445659
PubChem ID 185460
TTD Drug ID Not Available
NDC Product Code 42765-045
UNII PA1123N395
Synonyms bilastine
Chemical Information
Molecular Formula C28H37N3O3
CAS Registry Number 202189-78-4
SMILES CCOCCN1C2=CC=CC=C2N=C1C3CCN(CC3)CCC4=CC=C(C=C4)C(C)(C)C(=O)O
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Neuralgia17.02.07.005--
Pain08.01.08.004--
Pain in extremity15.03.04.010--
Palpitations02.11.04.012--
Paraesthesia17.02.06.005; 23.03.03.094--
Pruritus23.03.12.001--
Rash23.03.13.001--Not Available
Stress19.06.02.004--Not Available
Swelling08.01.03.015--Not Available
Swelling face08.01.03.100; 23.04.01.018; 10.01.05.018--Not Available
Swollen tongue23.04.01.014; 10.01.05.015; 07.14.02.003--Not Available
Tachycardia02.03.02.007--Not Available
Therapeutic response decreased08.06.01.016--Not Available
Throat irritation22.12.03.029; 07.05.05.037--Not Available
Tinnitus17.04.07.004; 04.04.01.002--
Tremor17.01.06.002--
Urticaria23.04.02.001; 10.01.06.001--
Peripheral swelling08.01.03.053; 02.05.04.015--Not Available
Eye pruritus06.04.05.006--Not Available
Respiratory tract congestion22.02.07.003--Not Available
Juvenile idiopathic arthritis15.01.03.004; 10.04.06.004--Not Available
Autoimmune disorder10.04.04.003--
Hyperlipidaemia14.08.03.001--
Oropharyngeal pain22.12.03.016; 07.05.05.004--
Chronic spontaneous urticaria10.01.06.011; 23.04.02.011--Not Available
Sensitivity to weather change08.01.03.077--Not Available
Lower respiratory tract congestion22.12.01.004--Not Available
Illness08.01.03.091--Not Available
Therapeutic product effect decreased08.06.01.050--Not Available
Therapeutic product effect incomplete08.06.01.052--Not Available
The 2th Page    First    Pre   2 3    Next   Last    Total 3 Pages